Influence of Elastic Tape on Activation of the Quadriceps Muscle During Selected Resisted and Weight Bearing Exercises

May 18, 2022 updated by: Michelle Dolphin, State University of New York - Upstate Medical University
This cross over design study will be used to determine the influence of elastic kinesiology tape on the speed and amplitude of quadriceps activation (anterior thigh) during selected resisted and weight bearing exercises.

Study Overview

Detailed Description

Objective: This cross over design study will be used to determine the influence of elastic kinesiology tape on the speed and amplitude of quadriceps activation (anterior thigh) during selected resisted and weight bearing exercises.

Background: Compliant tape, such as KiniseoⓇ Tape (KT), is highly elastic and claimed by the manufacturer to mimic skin. It is commonly used by physical therapists and sports medicine practitioners to treat musculoskeletal conditions and to enhance physical performance. The creators of KT teach a variety of applications techniques to affect the underlying musculature. Current theory regarding elastic tape application suggests that if the tape is applied over a muscle from the proximal to distal attachments, it will facilitate the underlying muscle while applying the tape from distal to proximal will inhibit the musculature.1 While studies have investigated the effect of elastic tape on muscle activation, few studies to date have compared the direction of application on muscle activation.2-7

Methods and Measures: Healthy subjects between 18-35 years old will be recruited from the Upstate Medical University community via email and word of mouth. Potential participants will report to the Institute for Human Performance and will be asked to complete all documentation including informed consent and a health-screening questionnaire. If eligible, qualified participants will perform 2 functional jumping exercises (vertical jump and single-leg triple hop for distance) 8 and isokinetic knee flexion and extension at 60 degrees/sec and 120 degrees/sec using the Biodex System 3 Pro Dynamometer (Biodex Medical Systems, Shirley, NY). The Biodex isokinetic machine has been shown to be a reliable and valid source of measuring peak torque, position and velocity.9 Surface electromyography (EMG) recordings will be collected from the vastus medialis and vastus lateralis during isokinetic testing. Testing will occur over four sessions. In the first session, baseline measurements and measurements immediately after KT application will be collected. In the second session, the participant will be retested after wearing the KT for up to two days (48 hours). This process will be repeated one week later during sessions three and four with KT applied in the opposite direction of the initial testing condition. KT application direction and the order of activities will be randomized for each participant.

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Eligible participants were between the ages of 18 to 35 and naïve to the use of kinesiology tape. Exclusion criteria included musculoskeletal injury to the lower extremities (within the previous year), past surgery to the lower extremities, or known allergy to adhesive tape.

All participants were screened for physical activity and exercise testing using the Physical Activity and Readiness Questionnaire (PAR-Q)15 (British Columbia Ministry of Health, British Columbia/Canada), resting vital signs, and American College of Sports Medicine guidelines for exercise testing. The Physical Activity and Readiness Questionnaire (PAR-Q)(British Columbia Ministry of Health) will be used as a general screen of exercise safety. Additionally, researchers will ask participants to identify possible cardiovascular and/or orthopedic risks to resistance exercise, dominant leg injuries/surgeries, and regarding history or familiarity of elastic tape. Subjects who are at risk due to recent (within the last year) musculoskeletal injury to lower extremities will be excluded from the study. Additionally, we will exclude subjects who report significant respiratory-cardiovascular disease, subjects with a history of surgery on their dominant leg, or individuals who have been trained in elastic tape theory and application. Any participant with a known allergy to adhesives will also be excluded from the study. Blood pressure and heart rate will be measured at the start of each session. Per ACSM's guidelines for exercise testing, if a participant's resting systolic blood pressure is greater than >200 mm Hg or diastolic BP is >110 mm Hg then he/she will be excluded from exercise testing and the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Distal to Proximal Tape
Quadriceps muscle taped (Using Kinesio Tape) starting distal by knee and ending proximal by hip.
Elastic tape placed over the skin
Experimental: Proximal to Distal Tape
Quadriceps muscle taped (Using Kinesio Tape) starting proximal by hip and ending distal by knee.
Elastic tape placed over the skin

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Vertical Jump Height Immediately Post Tape Administration
Time Frame: Immediate
Vertical Jump Height Immediately Post Tape Administration
Immediate
Unilateral Three Hop for Distance Immediately Post Tape Administration
Time Frame: Immediate
Unilateral three hop for distance immediately post tape administration
Immediate

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
EMG During Isokinetic Testing at 120 Degrees/Sec Immediately Post Tape Application
Time Frame: Immediate
EMG data were collected during the isokinetic testing at 120 degrees/sec Immediately Post Tape Application
Immediate
EMG During Isokinetic Testing at 60 Degrees/Sec Immediately Post Tape Application
Time Frame: Immediate
EMG during isokinetic testing at 60 degrees/second Immediately Post Tape Application
Immediate
Isokinetic Torque at 120 Degrees/Sec Immediately Post Tape Administration
Time Frame: Immediate
Isokinetic Torque at 120 Degrees/Second Immediately Post Tape Administration
Immediate
Isokinetic Torque at 60 Degrees/Sec Immediately Post Tape Administration
Time Frame: Immediate
Isokinetic Torque at 60 Degrees/Second Immediately Post Tape Administration
Immediate

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michelle Dolphin, DPT, SUNY Upstate Medical

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2015

Primary Completion (Actual)

May 1, 2016

Study Completion (Actual)

December 1, 2016

Study Registration Dates

First Submitted

December 9, 2014

First Submitted That Met QC Criteria

December 11, 2014

First Posted (Estimate)

December 17, 2014

Study Record Updates

Last Update Posted (Actual)

June 14, 2022

Last Update Submitted That Met QC Criteria

May 18, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • SUMU-PT-KTAP1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

No individual participant data will be shared.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Subjects

Clinical Trials on Kinesio Tape

Subscribe